Series A · Healthtech
Lissun raises ₹48 crore Series A led by Colossa Ventures
The company plans more Sunshine child-development centres and investment in AI-led tools.
Lissun announced ₹48 crore in Series A funding on August 18, 2026, led by Colossa Ventures. Physis Capital, RPSG Capital Ventures, IvyCap Ventures, Rainmatter, Multiply Ventures and SucSEED Ventures joined the round, alongside new investors New Age India Fund and Beyond Capital Ventures.
The company plans to expand its Sunshine by LISSUN centre network and develop AI-led products and clinical processes. At the announcement, it said it operated 25 centres and conducted more than 10,000 therapy sessions each month, with plans to reach 50 centres in 2027.
Use of funds
Sunshine centre expansion
AI-led products
Clinical process development